EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Early Adoption of Thyroid Radiofrequency Ablation in Canada: Physician Experiences, Barriers, and Facilitators to Implementation

Harrison Gao iD, David Liu, Ben B Levy, Justin Shapiro iD, Kevin M Higgins, Diana E Khalil, Elizabeth E Cottrill, Courtney Poon, Pabiththa Kamalraj, Justine Philteos, Antoine Eskander

Journal of Otolaryngology - Head & Neck Surgery · 2026-06 · 55

DOI: 10.1177/19160216261451820 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Otolaryngology - Head & Neck Surgery, online erschienen am 18.06.2026. Verfasst von Harrison Gao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Radiofrequency Ablation, Thyroid Nodule, Practice Patterns, Physicians'. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance: Thyroid radiofrequency ablation (RFA) is a minimally invasive alternative to surgery for thyroid nodules. Despite strong international evidence, thyroid RFA was only approved by Health Canada in April 2023. Understanding the experiences of early adopters can inform the broader adoption of RFA in Canada and other healthcare systems.

Objective

To describe the implementation experiences of early adopters of thyroid RFA in Canada and identify barriers and facilitators to adoption.

Design

Multiple methods.

Setting

All 8 listed RFA facilities in Canada.

Participants

Physicians performing thyroid RFA (n = 9). Main Outcome Measures: Survey and semi-structured interviews.

Results

Most participants reported low RFA volumes (median [IQR] = 2.0 [0.6-3.0] cases/month) and short wait times (1.5 [1.0-2.0] months). For thyroid surgery on similar nodules, participants performed higher volumes (7.5 [6.0-10.2] cases/month, P = .01) and had longer wait times (6.0 [5.5-8.5] months, P < .01). Four major themes emerged: (1) financial barriers and inequity; (2) impact on the healthcare system; (3) learning curve; and (4) motivators and facilitators. Financial barriers were driven by the RFA generator ($40 500 CAD) and single-use probes ($1500-$2500 CAD). RFA was funded privately out-of-pocket in most physician practices (n = 7) and rarely publicly covered (n = 2). Motivators and facilitators included patient-centred benefits, professional development, institutional support, and potential resource savings.

Conclusions

Thyroid RFA adoption in Canada is in its infancy, characterized by low procedural volumes, few providers, and geographical disparities. Early adopters reported positive experiences with RFA. However, inconsistent funding models, billing codes, and policy frameworks have resulted in inequitable access for patients. Relevance: Many healthcare systems are in the early stages of RFA adoption, similar to Canada. This study identifies key experiences, barriers, and facilitators applicable to physicians, leaders, and policymakers globally who are interested in adopting RFA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Radiofrequency AblationThyroid NodulePractice Patterns, Physicians'HumansCanadaAttitude of Health Personnel

Stichwörter der Autor:innen

barriers and facilitatorshealth policyphysician experiencesthyroid nodulethyroid radiofrequency ablation

Autor:innen und Institutionen

  • Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
  • Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON, Canada.
  • Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Department of Medicine, Queen's University, Kingston, ON, Canada.
  • Department of Otolaryngology - Head & Neck Surgery, University of Toronto, Toronto, ON, Canada.
  • Department of Otolaryngology - Head & Neck Surgery, Western University, London, ON, Canada.

ORCID-Profile: Harrison Gao, Justin Shapiro

Zitieren

APA

Gao, H., Liu, D., Levy, B. B., Shapiro, J., Higgins, K. M., Khalil, D. E., Cottrill, E. E., Poon, C., Kamalraj, P., Philteos, J., & Eskander, A. (2026). Early Adoption of Thyroid Radiofrequency Ablation in Canada: Physician Experiences, Barriers, and Facilitators to Implementation. Journal of Otolaryngology - Head & Neck Surgery, 55. https://doi.org/10.1177/19160216261451820

Vancouver

Gao H, Liu D, Levy BB, Shapiro J, Higgins KM, Khalil DE, et al. Early Adoption of Thyroid Radiofrequency Ablation in Canada: Physician Experiences, Barriers, and Facilitators to Implementation. Journal of Otolaryngology - Head & Neck Surgery. 2026;55. doi:10.1177/19160216261451820

BibTeX
@article{Gao2026,
  author = {Gao, Harrison and Liu, David and Levy, Ben B and Shapiro, Justin and Higgins, Kevin M and Khalil, Diana E and Cottrill, Elizabeth E and Poon, Courtney and Kamalraj, Pabiththa and Philteos, Justine and Eskander, Antoine},
  title = {Early Adoption of Thyroid Radiofrequency Ablation in Canada: Physician Experiences, Barriers, and Facilitators to Implementation},
  journal = {Journal of Otolaryngology - Head & Neck Surgery},
  year = {2026},
  volume = {55},
  doi = {10.1177/19160216261451820}
}
Kostenlos starten →